BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17392412)

  • 1. Differential effects of CRF1 and CRF2 receptor antagonists on pain-related sensitization of neurons in the central nucleus of the amygdala.
    Ji G; Neugebauer V
    J Neurophysiol; 2007 Jun; 97(6):3893-904. PubMed ID: 17392412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro- and anti-nociceptive effects of corticotropin-releasing factor (CRF) in central amygdala neurons are mediated through different receptors.
    Ji G; Neugebauer V
    J Neurophysiol; 2008 Mar; 99(3):1201-12. PubMed ID: 18171711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential mechanisms of CRF1 and CRF2 receptor functions in the amygdala in pain-related synaptic facilitation and behavior.
    Fu Y; Neugebauer V
    J Neurosci; 2008 Apr; 28(15):3861-76. PubMed ID: 18400885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-pain-related CRF1 activation in the amygdala facilitates synaptic transmission and pain responses.
    Ji G; Fu Y; Adwanikar H; Neugebauer V
    Mol Pain; 2013 Feb; 9():2. PubMed ID: 23410057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Block of NMDA and non-NMDA receptor activation results in reduced background and evoked activity of central amygdala neurons in a model of arthritic pain.
    Li W; Neugebauer V
    Pain; 2004 Jul; 110(1-2):112-22. PubMed ID: 15275758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala.
    Ji G; Fu Y; Ruppert KA; Neugebauer V
    Mol Pain; 2007 Jun; 3():13. PubMed ID: 17550594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential changes of group II and group III mGluR function in central amygdala neurons in a model of arthritic pain.
    Li W; Neugebauer V
    J Neurophysiol; 2006 Oct; 96(4):1803-15. PubMed ID: 16760343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons.
    Li W; Neugebauer V
    J Neurophysiol; 2004 Jan; 91(1):13-24. PubMed ID: 13679408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of type 1 corticotropin-releasing factor receptor in the guinea pig enteric nervous system.
    Liu S; Gao X; Gao N; Wang X; Fang X; Hu HZ; Wang GD; Xia Y; Wood JD
    J Comp Neurol; 2005 Jan; 481(3):284-98. PubMed ID: 15593376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
    Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
    Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of corticotropin releasing factor(CRF) on somatic pain sensitivity in conscious rats: involvement of CRF1 and CRF2 receptors].
    Iarushkina NI; Bagaeva TR; Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2014 Nov; 100(11):1287-96. PubMed ID: 25665407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
    Oliveira LA; Almeida J; Benini R; Crestani CC
    Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.
    Risbrough VB; Hauger RL; Roberts AL; Vale WW; Geyer MA
    J Neurosci; 2004 Jul; 24(29):6545-52. PubMed ID: 15269266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis.
    Kash TL; Winder DG
    Neuropharmacology; 2006 Oct; 51(5):1013-22. PubMed ID: 16904135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of mGluR7 and mGluR8 activation on pain-related synaptic activity in the amygdala.
    Ren W; Palazzo E; Maione S; Neugebauer V
    Neuropharmacology; 2011 Dec; 61(8):1334-44. PubMed ID: 21854791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain.
    Neugebauer V; Li W
    J Neurophysiol; 2003 Feb; 89(2):716-27. PubMed ID: 12574449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NR2B receptor blockade inhibits pain-related sensitization of amygdala neurons.
    Ji G; Horváth C; Neugebauer V
    Mol Pain; 2009 Apr; 5():21. PubMed ID: 19400952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor (CRF) receptor subtypes in mediating neuronal activation of brain areas involved in responses to intracerebroventricular CRF and stress in rats.
    Takahashi C; Ohata H; Shibasaki T
    Peptides; 2011 Dec; 32(12):2384-93. PubMed ID: 21964377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRF modulates glutamate transmission in the central amygdala of naïve and ethanol-dependent rats.
    Varodayan FP; Correia D; Kirson D; Khom S; Oleata CS; Luu G; Schweitzer P; Roberto M
    Neuropharmacology; 2017 Oct; 125():418-428. PubMed ID: 28807676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.